Mehdi Gasmi, Director at Adverum Biotechnologies, Inc. (ADVM), sold 50,000 shares at $18.11 ($917K) on 2020-05-18, disclosed to the SEC on 2020-05-20.
Open-market sale of $917k ADVM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.26 | 10,000 | $163K | 17.7% |
| 2 | $16.26 | 10,000 | $163K | 17.7% |
| 3 | $20.03 | 25,000 | $501K | 54.6% |
| 4 | $18.11 | 4,700 | $85K | 9.3% |
| 5 | $19.03 | 300 | $6K | 0.6% |
| Total | $18.34 avg | 50,000 |
| $917K |
| 100% |
| Filing → |
| ADVM | SELL | 2020-06-18 | $563K | — | Filing → |
| ADVM | SELL | 2020-06-17 | $324K | — | Filing → |
| ADVM | SELL | 2020-05-22 | $100K | — | Filing → |